Sukhani R, Vazquez J, Pappas A L, Frey K, Aasen M, Slogoff S
Department of Anesthesiology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Anesth Analg. 1996 Nov;83(5):975-81. doi: 10.1097/00000539-199611000-00013.
This prospective, randomized double-blind study was conducted to examine the effect of intraoperative opioid (fentanyl) supplementation on postoperative analgesia, emesis, and recovery in ambulatory patients receiving propofol-nitrous oxide anesthesia. Eighty patients undergoing ambulatory gynecologic laparoscopy participated. Confounding variables that could influence the incidence of postoperative emesis were controlled. Patients received either fentanyl 100 micrograms (Group I) or ketorolac 60 mg (Group II) intravenously (IV) at the time of anesthetic induction. No further analgesic supplements were given intraoperatively. Anesthesia was induced with propofol and maintained with propofol-nitrous oxide. Atracurium was used for muscle relaxation and reversed with neostigmine and glycopyrrolate. Postoperative pain during early recovery was treated with IV fentanyl 25-50 micrograms (Group I) or IV ketorolac 15-30 mg (Group II). Subsequent breakthrough pain in both groups was treated with IV fentanyl 25 micrograms increments as needed (rescue analgesia). Eighty-four percent of patients in Group I required analgesics during early recovery versus 56% of patients in Group II (P < 0.05). Maintenance dose of propofol was significantly lower in Group I (129 +/- 35 micrograms.kg-1.min-1 than in Group II (170 +/- 63 micrograms.kg-1.min-1. Immediate recovery (emergence) in the two groups was comparable, despite different propofol requirements. Although the incidence of emetic sequelae in the postanesthesia care unit was not significantly different between the two treatment groups, a significantly larger number of patients in Group I (fentanyl group) had emetic sequelae that required therapeutic intervention (Group I 29% versus Group II 10%). Patients in Group I also took a significantly longer time to ambulate and meet criteria for home discharge. These results indicate that, in patients undergoing ambulatory gynecologic laparoscopy, the practice of administering a small dose of fentanyl at the time of anesthetic induction reduces maintenance propofol requirement, but fails to provide effective postoperative analgesia. Fentanyl administration at anesthetic induction increased the need for rescue antiemetics. The relative severity of emetic sequelae could have contributed to delay in ambulation and discharge.
本前瞻性随机双盲研究旨在探讨术中补充阿片类药物(芬太尼)对接受丙泊酚 - 氧化亚氮麻醉的门诊患者术后镇痛、呕吐及恢复情况的影响。80例接受门诊妇科腹腔镜手术的患者参与了研究。对可能影响术后呕吐发生率的混杂变量进行了控制。患者在麻醉诱导时静脉注射100微克芬太尼(I组)或60毫克酮咯酸(II组)。术中未给予进一步的镇痛补充剂。麻醉诱导采用丙泊酚,维持采用丙泊酚 - 氧化亚氮。使用阿曲库铵进行肌肉松弛,并使用新斯的明和格隆溴铵进行拮抗。早期恢复期间的术后疼痛,I组采用静脉注射25 - 50微克芬太尼治疗,II组采用静脉注射15 - 30毫克酮咯酸治疗。两组随后的突破性疼痛均根据需要以25微克递增剂量静脉注射芬太尼进行治疗(解救镇痛)。I组84%的患者在早期恢复期间需要镇痛,而II组为56%(P < 0.05)。I组丙泊酚维持剂量(129±35微克·千克⁻¹·分钟⁻¹)显著低于II组(170±63微克·千克⁻¹·分钟⁻¹)。尽管丙泊酚需求量不同,但两组的即刻恢复(苏醒)情况相当。虽然两个治疗组在麻醉后护理单元的呕吐后遗症发生率无显著差异,但I组(芬太尼组)有显著更多的患者出现需要治疗干预的呕吐后遗症(I组为29%,II组为10%)。I组患者行走并达到出院标准所需的时间也显著更长。这些结果表明,在接受门诊妇科腹腔镜手术的患者中,麻醉诱导时给予小剂量芬太尼的做法可降低丙泊酚维持需求量,但未能提供有效的术后镇痛。麻醉诱导时给予芬太尼增加了对抗呕吐解救药物的需求。呕吐后遗症的相对严重程度可能导致了行走和出院延迟。